Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Polarized microscopy is a quick and free method to correctly identify types of hair loss.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Scanning electron microscopy revealed four distinct hair root shapes in alopecia areata, suggesting a less invasive diagnostic method.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Trichoscopy is crucial for diagnosing and assessing alopecia areata in children.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Many people diagnosed with androgenic alopecia might actually have hidden scarring or inflammation.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.